Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Odyssey Therapeutics, Inc.

Odyssey Therapeutics, Inc.

Stage unknownBoston, MABiotechnology
Facts
Year of incorporation
2021sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
2 rounds
  1. Jun 16, 2025
    Form D equity offering · $214M (form d sold) · 55 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Odyssey Therapeutics, Inc. filed Form D: $214,025,200 sold of $214,025,200, Biotechnology”
  2. Oct 25, 2023
    Form D equity offering · $117M (form d sold) · 43 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Odyssey Therapeutics, Inc. filed Form D/A: $117,210,000 sold of $121,080,000, Biotechnology”
Investors on record
1 edges
People
2 officers, 17 directors
Timeline
2
  1. Dec 4, 2025
    Odyssey Therapeutics, Inc. filed Form D: $214,025,200 sold of $214,025,200, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Aug 14, 2024
    Odyssey Therapeutics, Inc. filed Form D/A: $117,210,000 sold of $121,080,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
32 observations
Every observation on this company